e-learning
resources
Amsterdam 2011
Monday, 26.09.2011
Treatment options and tumour biology of malignant pleural mesothelioma
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
mTOR inhibition blocks tumor growth and pleural fluid accumulation in experimental murine mesothelioma
M. Vazakidou, S. Magouta, C. Moschos, M. Stratiki, C. Roussos, I. Kalomenidis (Athens, Greece)
Source:
Annual Congress 2011 - Treatment options and tumour biology of malignant pleural mesothelioma
Session:
Treatment options and tumour biology of malignant pleural mesothelioma
Session type:
Oral Presentation
Number:
2947
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Vazakidou, S. Magouta, C. Moschos, M. Stratiki, C. Roussos, I. Kalomenidis (Athens, Greece). mTOR inhibition blocks tumor growth and pleural fluid accumulation in experimental murine mesothelioma. Eur Respir J 2011; 38: Suppl. 55, 2947
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
All-
trans
-retinoic acid inhibits tumor growth of malignant pleural mesothelioma in mice
Source: Annual Congress 2010 - Basic mechanisms in malignant pleural disease biology
Year: 2010
The inhibitory effect of PI3k inhibitor and MEK inhibitor on malignant pleural mesothelioma cell growth
Source: Annual Congress 2009 - Pleural and mediastinal diseases
Year: 2009
All-trans-retinoic acid inhibits tumour growth of malignant pleural mesothelioma in mice
Source: Eur Respir J 2009; 34: 1159-1167
Year: 2009
Forced chemokine ligand 2 overexpression renders melanoma cells capable of inducing experimental malignant pleural effusion
Source: Annual Congress 2008 - Novel trends in functional genomics and molecular pathology of neoplastic and non-neoplastic lung diseases
Year: 2008
The proteasome inhibitor bortezomib is effective against experimental malignant pleural effusion
Source: Annual Congress 2008 - Novel targets in the molecular pathology of lung cancer and COPD
Year: 2008
Studying the biological properties of pleural fluid: pleural fluid alone is adequate for cancer cell proliferation in vitro
Source: Virtual Congress 2020 – Malignant pleural effusion in 2020: understanding the biology and clinical implications
Year: 2020
Dissecting the mTOR pathway in malignant pleural mesothelioma
Source: Annual Congress 2010 - Basic mechanisms in malignant pleural disease biology
Year: 2010
Prognostic role of inflammatory cells in blood, pleural fluid and tumour samples, in patients with malignant pleural mesothelioma (MPM)
Source: International Congress 2017 – Mesothelioma and malignant pleural disease
Year: 2017
Novel Synthetic lignan reduces asbestos-induced damage in human pleural mesothelial cells-Potential clinical usefulness in inhibiting pleural malignant mesothelioma
Source: International Congress 2017 – Mesothelioma and malignant pleural disease
Year: 2017
Malignant pleural effusion cells show aberrant glucose metabolism gene expression
Source: Eur Respir J 2011; 37: 1453-1465
Year: 2011
ADAM10 membrane-bound protease mediates malignant pleural mesothelioma invasiveness
Source: International Congress 2018 – Mesothelioma and pleural malignancy: investigations and management
Year: 2018
RNA is favourable for analysing EGFR mutations in malignant pleural effusion of lung cancer
Source: Eur Respir J 2012; 39: 677-684
Year: 2012
Early pleural fluid control is warranted to prevent reaccumulation of malignant pleural effusion in oncogene-driven lung cancer
Source: International Congress 2019 – Brain Metastasis and Malignant pleural effusion: improving our understanding
Year: 2019
Diagnostic value of detection of promoter hypermethylation of tumor suppressor genes in pleural fluid for diagnosis of malignant pleural effusion
Source: Annual Congress 2010 - Lung cancer, idiopathic pulmonary fibrosis and sarcoidosis: the genetic approach
Year: 2010
Effects of mTOR Inhibition in malignant mesothelioma
Source: Annual Congress 2010 - Basic mechanisms in malignant pleural disease biology
Year: 2010
Proliferation controlling intercellular signalling pathways in human pleural malignant mesothelioma
Source: Annual Congress 2007 - Pleural malignancy
Year: 2007
The therapeutic efficacy of troglitazone in combination with cisplatin against malignant pleural mesothelioma cell growth
Source: Annual Congress 2010 - Current issues in malignant pleural diseases
Year: 2010
Antitumor activity of MEK and PI3K inhibitors in malignant pleural mesothelioma
Source: Annual Congress 2011 - Treatment options and tumour biology of malignant pleural mesothelioma
Year: 2011
Frequent epidermal growth factor receptor gene mutations in malignant pleural effusion of lung adenocarcinoma
Source: Eur Respir J 2008; 32: 924-930
Year: 2008
Talc mediates angiostasis in malignant pleural effusions via endostatin induction
Source: Eur Respir J 2007; 29: 761-769
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept